Page 295

House Bill No. 5506

Public Act No. 22-118 295 of 739

insurance reimbursement considerations and standards of treatment facilities; (3) advising the department on the use of group therapy and other therapy options to reduce cost and maximize public health benefits from psychedelic treatments; (4) monitoring updated federal regulations and guidelines for referral and consideration by the state agencies of cognizance for implementation of such regulations and guidelines; (5) developing a long-term strategic plan to improve mental health care through the use of psychedelic treatment; (6) recommending equity measures for clinical subject recruitment and facilitator training recruitment; and (7) assisting with the development of public awareness and education campaigns. (f) The board may establish committees and subcommittees necessary for the operation of the board. Sec. 202. Section 21a-243 of the general statutes is repealed and the following is substituted in lieu thereof (Effective July 1, 2022): (a) The Commissioner of Consumer Protection shall adopt regulations for the efficient enforcement and operation of sections 21a- 244 to 21a-282, inclusive. (b) The Commissioner of Consumer Protection may, so far as may be consistent with sections 21a-244 to 21a-282, inclusive, adopt the regulations existing under the federal Controlled Substances Act and pertinent regulations existing under the federal food and drug laws and conform regulations adopted hereunder with those existing under the federal Controlled Substances Act and federal food and drug laws. (c) The Commissioner of Consumer Protection, acting upon the advice of the Commission of Pharmacy, may by regulation designate, after investigation, as a controlled substance, a substance or chemical composition containing any quantity of a substance which has been found to have a stimulant, depressant or hallucinogenic effect upon the